The global Huntington's disease treatment market is predicted to be valued US$ 360 million in 2021 and to increase at a CAGR of 20% between 2022 and 2032. The market is expected to be worth $2.7 billion by the end of 2032. The Huntington's Disease Treatment market stands at the intersection of medical innovation and the pursuit of effective therapeutic interventions for a complex...